Form 4: Axon Enterprise President Joshua Isner Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Axon Enterprise's President, Joshua Isner, sold a total of 3,780 shares of common stock between December 2nd and December 4th, 2024, under a pre-arranged 10b5-1 trading plan.
Summary
- Joshua Isner, President of Axon Enterprise, Inc., executed multiple transactions involving the company's common stock.
- On December 2, 2024, shares were sold to cover tax liabilities from vesting restricted stock units.
- Between December 2nd and December 4th, 2024, a total of 3,780 shares were sold under a pre-arranged 10b5-1 trading plan.
- The sales were executed at various prices, ranging from $636.39 to $667.09 per share.
- The transactions resulted in a decrease in Isner's direct holdings of Axon common stock from 187,873 to 184,151 shares.
Sentiment
Score: 5
Explanation: The document is a routine disclosure of stock sales by an executive under a pre-arranged plan. It does not indicate any positive or negative sentiment.
Risks
- Executive stock sales can sometimes be perceived negatively by the market, potentially impacting investor sentiment.
Industry Context
Executive stock sales are a common occurrence, and the use of a 10b5-1 plan is a standard practice to avoid accusations of insider trading. This filing is a routine disclosure of such transactions.
Comparison to Industry Standards
- The use of a 10b5-1 trading plan is a common practice among executives at publicly traded companies, including those in the technology and law enforcement sectors, such as Motorola Solutions and Digital Ally.
- These plans allow executives to sell shares at predetermined times and prices, mitigating the risk of insider trading allegations.
- The reported transactions are consistent with standard executive compensation practices and do not indicate any unusual activity compared to peers.
Stakeholder Impact
- The stock sales may have a minor impact on shareholder sentiment, but the use of a 10b5-1 plan suggests the transactions were planned and not based on any new information.
Key Dates
| Date | Description |
|---|---|
| 09/15/2023 | Date the 10b5-1 trading plan was adopted by Joshua Isner. |
| 12/02/2024 | Date of the first reported stock sale and tax liability settlement. |
| 12/03/2024 | Date of multiple stock sales under the 10b5-1 plan. |
| 12/04/2024 | Date of the final reported stock sale and the filing date of the Form 4. |
Keywords
Axon Enterprise, Joshua Isner, stock sale, Form 4, 10b5-1 plan, insider trading, executive compensation, share transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.